VentureBeat

Posts Tagged ‘grant’

Read the rest of this entry »

Baltimore, Md.-based Profectus BioSciences, a biotech developing new strategies to attack HIV, received a $200,000 small-business innovation grant from the National Institutes of Health to improve the effectiveness of anti-HIV antibodies. Last month, the company received a similar $300,000 grant (PDF link), just a few days after the company raised $3 million in a private placement.

Profectus, which was spun out of the Institute for Human Virology in 2005, has so far rased a total of at least $6.5 million.

Snowdon, a New Brunswick, N.J., drug developer, received a $500,000 grant from the New Jersey Commission on Science & Technology. The grant matches $500,000 the company raised in March from the Foundation Venture Capital Group.

Snowdon is developing new treatments against cancer, pain and infectious parasitic diseases.

Top Stories

Recent Comments

Powered by Disqus

Recent Guest Columnists

Job Board

Links

Venturebeat Writers

  • For advertising, contact .
  • Log in

Font Size